157 related articles for article (PubMed ID: 25212656)
1. Berberine interfered with breast cancer cells metabolism, balancing energy homeostasis.
Tan W; Li N; Tan R; Zhong Z; Suo Z; Yang X; Wang Y; Hu X
Anticancer Agents Med Chem; 2015; 15(1):66-78. PubMed ID: 25212656
[TBL] [Abstract][Full Text] [Related]
2. Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway.
Patil JB; Kim J; Jayaprakasha GK
Eur J Pharmacol; 2010 Oct; 645(1-3):70-8. PubMed ID: 20691179
[TBL] [Abstract][Full Text] [Related]
3. Berberine as a promising safe anti-cancer agent - is there a role for mitochondria?
Diogo CV; Machado NG; Barbosa IA; Serafim TL; Burgeiro A; Oliveira PJ
Curr Drug Targets; 2011 Jun; 12(6):850-9. PubMed ID: 21269266
[TBL] [Abstract][Full Text] [Related]
4. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest.
Kim JB; Yu JH; Ko E; Lee KW; Song AK; Park SY; Shin I; Han W; Noh DY
Phytomedicine; 2010 May; 17(6):436-40. PubMed ID: 19800775
[TBL] [Abstract][Full Text] [Related]
5. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
6. Anti-mitochondrial therapy in human breast cancer multi-cellular spheroids.
Mandujano-Tinoco EA; Gallardo-Pérez JC; Marín-Hernández A; Moreno-Sánchez R; Rodríguez-Enríquez S
Biochim Biophys Acta; 2013 Mar; 1833(3):541-51. PubMed ID: 23195224
[TBL] [Abstract][Full Text] [Related]
7. Berberine inhibits the proliferation and migration of breast cancer ZR-75-30 cells by targeting Ephrin-B2.
Ma W; Zhu M; Zhang D; Yang L; Yang T; Li X; Zhang Y
Phytomedicine; 2017 Feb; 25():45-51. PubMed ID: 28190470
[TBL] [Abstract][Full Text] [Related]
8. The α-tocopherol derivative ESeroS-GS induces cell death and inhibits cell motility of breast cancer cells through the regulation of energy metabolism.
Zhao L; Zhao X; Zhao K; Wei P; Fang Y; Zhang F; Zhang B; Ogata K; Mori A; Wei T
Eur J Pharmacol; 2014 Dec; 745():98-107. PubMed ID: 25446928
[TBL] [Abstract][Full Text] [Related]
9. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes.
Ma X; Zhou J; Zhang CX; Li XY; Li N; Ju RJ; Shi JF; Sun MG; Zhao WY; Mu LM; Yan Y; Lu WL
Biomaterials; 2013 Jun; 34(18):4452-65. PubMed ID: 23518403
[TBL] [Abstract][Full Text] [Related]
10. Energy Metabolism Drugs Block Triple Negative Breast Metastatic Cancer Cell Phenotype.
Pacheco-Velázquez SC; Robledo-Cadena DX; Hernández-Reséndiz I; Gallardo-Pérez JC; Moreno-Sánchez R; Rodríguez-Enríquez S
Mol Pharm; 2018 Jun; 15(6):2151-2164. PubMed ID: 29746779
[TBL] [Abstract][Full Text] [Related]
11. Berberine combined with 2-deoxy-d-glucose synergistically enhances cancer cell proliferation inhibition via energy depletion and unfolded protein response disruption.
Fan LX; Liu CM; Gao AH; Zhou YB; Li J
Biochim Biophys Acta; 2013 Nov; 1830(11):5175-83. PubMed ID: 23872355
[TBL] [Abstract][Full Text] [Related]
12. Isoflurane promotes glucose metabolism through up-regulation of
Guo NL; Zhang JX; Wu JP; Xu YH
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28951521
[TBL] [Abstract][Full Text] [Related]
13. Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1.
Fodor T; Szántó M; Abdul-Rahman O; Nagy L; Dér Á; Kiss B; Bai P
PLoS One; 2016; 11(2):e0150232. PubMed ID: 26919657
[TBL] [Abstract][Full Text] [Related]
14. Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation.
Meeran SM; Katiyar S; Katiyar SK
Toxicol Appl Pharmacol; 2008 May; 229(1):33-43. PubMed ID: 18275980
[TBL] [Abstract][Full Text] [Related]
15. Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231.
Kim JB; Lee KM; Ko E; Han W; Lee JE; Shin I; Bae JY; Kim S; Noh DY
Planta Med; 2008 Jan; 74(1):39-42. PubMed ID: 18203057
[TBL] [Abstract][Full Text] [Related]
16. Bergapten induces metabolic reprogramming in breast cancer cells.
Santoro M; Guido C; De Amicis F; Sisci D; Cione E; Vincenza D; Donà A; Panno ML; Aquila S
Oncol Rep; 2016 Jan; 35(1):568-76. PubMed ID: 26459431
[TBL] [Abstract][Full Text] [Related]
17. Berberine, an isoquinoline alkaloid, inhibits the metastatic potential of breast cancer cells via Akt pathway modulation.
Kuo HP; Chuang TC; Tsai SC; Tseng HH; Hsu SC; Chen YC; Kuo CL; Kuo YH; Liu JY; Kao MC
J Agric Food Chem; 2012 Sep; 60(38):9649-58. PubMed ID: 22950834
[TBL] [Abstract][Full Text] [Related]
18. Proteomic and redox-proteomic analysis of berberine-induced cytotoxicity in breast cancer cells.
Chou HC; Lu YC; Cheng CS; Chen YW; Lyu PC; Lin CW; Timms JF; Chan HL
J Proteomics; 2012 Jun; 75(11):3158-76. PubMed ID: 22522123
[TBL] [Abstract][Full Text] [Related]
19. Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis.
Du J; Sun Y; Lu YY; Lau E; Zhao M; Zhou QM; Su SB
Anticancer Res; 2017 Nov; 37(11):6141-6151. PubMed ID: 29061795
[TBL] [Abstract][Full Text] [Related]
20. Docosahexaenoic acid attenuates breast cancer cell metabolism and the Warburg phenotype by targeting bioenergetic function.
Mouradian M; Kikawa KD; Dranka BP; Komas SM; Kalyanaraman B; Pardini RS
Mol Carcinog; 2015 Sep; 54(9):810-20. PubMed ID: 24729481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
